Latest Breaking News On - Josh mandel brehm - Page 1 : comparemela.com

ProMIS Neurosciences : Corporate Overview -March 29, 2024 at 07:41 am EDT

NASDAQ: PMN Corporate Presentation Legal Disclaimers This slide deck may contain certain.

Maggie shafmasterJohanne kaplanPatrick kirwinEugene williamsNeil cashmanLarry altstielWilliam wymanJosh mandel brehmGavin malenfantDavid wishartDan geffkenPromis neurosciences incLeadership teamAlzheimer associationPioneering solutions for neurodegenerative diseasesWorld health organization

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomJeff jacobsDee smithChris calabreseJosh mandel brehmTherapeutics corpFulcrum therapeutics incCorporate communicationsExchange commissionDrug administrationLifesci advisorsDiamond blackfan anemiaChief scientific officerChief executive officerPrivate securities litigation reform actSci advisors

Research from the Lab of CAMP4 Co-Founder Richard Young Shows That RNA Binding to Transcription Fact

Research from the Lab of CAMP4 Co-Founder Richard Young Shows That RNA Binding to Transcription Fact
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomRichard youngJonathane henningerKristie wallisJosh mandel brehmOzgur oksuzMember of the whitehead instituteMassachusetts institute of technologyGene regulation validatesMolecular cellWhitehead instituteMassachusetts institute

Hope for haploinsufficiency diseases | Popular Science

Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.

United statesCold spring harbor laboratoryNew yorkUnited kingdomWestchester countySan diegoTevard biosciencesDavid hampsonOrrin devinskyJenni barnaoKenneth myersAdrian krainerNavneet matharuGopi shankerSamantha gundelWarren lammert

ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr Gail M Farfel, as Chief Executive Officer

13.09.2022 - New CEO brings 25 years’ experience and successful track record in neurological and neuropsychiatric drug developmentTORONTO, Ontario and CAMBRIDGE, Massachusetts , Sept. 13, 2022 (GLOBE NEWSWIRE) - ProMIS Neurosciences, Inc. (Nasdaq: PMN) . Seite 1

United statesUnited kingdomEugene williamsMaggie shafmasterGene williamsJosh mandel brehmPromis neurosciences incChief executive officerIndependent directorsLarry altstielChief medical officerGavin malenfantChief operatingGail farfel